Lightnews — Scholar-powered news

Reposted by Alison Tree

Prof Christina Pagel @chrischirp.bsky.social · Jul 7

New comment piece by me & colleagues in @bmj.com on the using health data for research in UK

Processes are so complex and so slow now that less research is happening and we are wasting the enormous potential of the NHS to drive innovation

www.bmj.com/content/390/...

Health research in England is grinding to a halt

Wes Streeting, the UK health and social care secretary, announced in 2024 that “the NHS is broken” against a background of ballooning waiting lists, delays in disease detection, and reduced staff prod...

www.bmj.com

43 100

Reposted by Alison Tree

Deep Chakrabarti @deeponco.bsky.social · Jul 1

@alison-tree.bsky.social @ccparker.bsky.social #prostatecancer #pcsm

Science News @scinews.bsky.social · Jul 1

This review discusses the contemporary management of all stages of prostate cancer, enabling holistic individualization of treatment, and describes the promise of future research to further improve outcomes.

Open Access
acsjournals.onlinelibrary.wiley.com/doi/10.3322/...

2 3

Alison Tree @alison-tree.bsky.social · Jun 27

Excited to see the MARS trial highlighted here @cihangani.bsky.social @elekta.com @mrlconsortium.bsky.social @momentumstudy.bsky.social

2 7

Alison Tree @alison-tree.bsky.social · Jun 27

Pleasure to be at the MRI in RT symposium at USZ @mguckenberger.bsky.social Meme of the day goes to Luca Boldrini

2

Reposted by Alison Tree

Marina Khan @marina-khan.bsky.social · Jun 24

We had the SABR bone and nodes workshop today. @uksabr.bsky.social in collaboration with the RCR. Lots of discussion & learning for all within the SABR MDT. Collaboration at its best. Thank you to all those that attended and especially the speakers. @alison-tree.bsky.social @pattydiezh.bsky.social

1 3

Reposted by Alison Tree

Deep Chakrabarti @deeponco.bsky.social · Jun 13

Happy to share our review on hypo- and ultra-hypofractionation for prostate cancer radiotherapy, just published in Seminars in Radiation Oncology

@alison-tree.bsky.social @harshanigreen.bsky.social

Full-text link:
authors.elsevier.com/a/1lFrI3lXQo...

3 8

Alison Tree @alison-tree.bsky.social · Jun 12

Fantastic opening plenary at #UKOF25 by @charlesswanton.bsky.social Cancer initiation is not a simple matter of DNA damage from carcinogens. Forget everything you learned before!

1 9

Reposted by Alison Tree

Prostate Cancer UK Professionals @prostateukprofs.bsky.social · Jun 10

💥 Our Transformational Impact Awards are now OPEN! 💥

This call supports our larger-scale research investments covering high-quality discovery science through to translational and clinical research.

Submission deadline: 1pm, 23 September 2025

Apply now 👉 buff.ly/eCSnnCM

9 6

Alison Tree @alison-tree.bsky.social · Jun 3

We are looking for two exceptional consultant uro-oncologists to come and join our team in Sutton. Please see further details 👇

www.royalmarsden.nhs.uk/current-vaca...

Current vacancies | The Royal Marsden

www.royalmarsden.nhs.uk

2 3

Reposted by Alison Tree

Patty Diez @pattydiezh.bsky.social · Jun 2

A great opportunity to work in cutting edge #clinicaltrials within a fun multidisciplinary team @notchonctrainees.bsky.social

RTTQA @rttqa.bsky.social · Jun 2

Want to be part of shaping the future direction of RT research in the UK? An exciting opportunity has arisen to work as a research fellow within the @nihr.bsky.social RTTQA Group, based at Mount Vernon Cancer Centre.
For more info please DM us! #radonc #rtqa

www.nhsjobs.com/job/UK/Hertf...

Job vacancy: Research Fellow National Radiotherapy QA Team, East and North Hertfordshire Teaching NHS Trust, Northwood | trac.jobs

www.nhsjobs.com

1 1

Alison Tree @alison-tree.bsky.social · May 31

Great news! If you have an idea for a new radiotherapy trial, please find the email below

roberthuddart.bsky.social @roberthuddart.bsky.social · May 30

News for UK radiotherapy community.
Pleased to say that thanks to @macmillancancer we have been able to establish #ctrad.
We plan a proposals guidance meeting on 8.7.25
If you have a new trial idea and wish to attend please contact [email protected] to register

3

Alison Tree @alison-tree.bsky.social · May 23

Excited to see the HERMES trial results in print www.sciencedirect.com/science/arti...
Small trial but toxicity of 2 fractions looks promising at 24/27 Gy, no GI tox of G2 or higher out to 12 weeks @momentumstudy.bsky.social @icr.ac.uk

HERMES: Randomised trial of 2-fraction or 5-fraction MRI-guided adaptive prostate radiotherapy

To demonstrate safety and feasibility of 2-fraction stereotactic body radiotherapy (SBRT) for prostate cancer.This single centre, non-comparative, pha…

www.sciencedirect.com

3 7

Alison Tree @alison-tree.bsky.social · May 21

What could be better than 5 days in Verona in October, learning about prostate cancer? Comprehensive multidisciplinary programme aimed at oncologists, urologists, radiologists and anyone else involved in treated prostate cancer. Spread the word!

1 7 9

Alison Tree @alison-tree.bsky.social · May 19

Encouraging data on safety of 5-fraction SBRT for post-prostatectomy recurrence 👇

The Advanced Prostate Cancer Consensus Conference @apccc.bsky.social · May 19

Patient-Reported Outcomes With Stereotactic Intensity Modulated Radiotherapy After Radical Prostatectomy

jamanetwork.com/journals/jam...

findings suggest that post-RP SBRT is a well-tolerated alternative to Conventionally Fractionated RT
#ProstateCancer

@silkegillessen.bsky.social 🚨

Patient-Reported Outcomes With Stereotactic Intensity Modulated Radiotherapy After Radical Prostatectomy

This nonrandomized clinical trial evaluates physician-reported late toxic effects and 2-year patient-reported outcomes following post–radical prostatectomy stereotactic body radiotherapy.

jamanetwork.com

1 2

Alison Tree @alison-tree.bsky.social · May 9

Don’t forget to register for the annual UK Oncology forum, which is FREE to attend. Breakout sessions covering topics including prostate cancer and radiotherapy, including Dr Ben O’Leary @icr.ac.uk, Dr Rovel Colaco, Dr Katie Spencer and Prof Stefanie Corradini oncology-forum.co.uk/register/

Register today - 2025 Oncology Forum

Use this form to register for the 2025 Oncology Forum event including all of the high profile speakers from around the world.

oncology-forum.co.uk

2 7

Alison Tree @alison-tree.bsky.social · May 5

I think it’s too early to say with PACE B, not enough events, population has lower risk of recurrence than FLAME. Have to patiently wait for the 10 year PACE-B outcomes, or higher risk SBRT studies.

Alison Tree @alison-tree.bsky.social · May 5

Congratulations to Professor Faivre-Finn on the ESTRO Breur award, and using your platform to encourage us all to address gender inequality in academic radiation oncology 👏 #ESTRO25

1 8 28

Alison Tree @alison-tree.bsky.social · May 5

Congratulations to @montefiored.bsky.social for a great presentation of the ARISTOTLE trial 👏. Always learn a lot from an RCT, sometimes not the things you were expecting to learn #ESTRO2025

1 7

Alison Tree @alison-tree.bsky.social · May 5

Significant benefit to focal boost in prostate cancer out to 10 years in FLAME trial #ESTRO2025 Fifteen percent of men avoid further treatment just due to the boost 🏆

6

Reposted by Alison Tree

Ananya Choudhury @achoud72.bsky.social · May 4

Congratulations @montefiored.bsky.social & team 👏🏽 I remember talking to you in clinic about this as a registrar. Great to see the results and the impact for patients #ESTRO25 @thelancetoncol.bsky.social

3 10

Alison Tree @alison-tree.bsky.social · May 4

Great summary from Piet Ost, summarising what we know about systemic therapy +/- SBRT (and vice versa) in prostate oligomets #ESTRO25

4

Alison Tree @alison-tree.bsky.social · May 3

HYPO-RT-PC 10 year data presented at #ESTRO2025. Seven fractions def non-inferior to 39 fractions, suggestion that 7 fractions might even be more likely to cure?

2 12

Alison Tree @alison-tree.bsky.social · May 3

Exciting data presented in ESTRO 2025 plenary: 5 fraction adjuvant breast RT (26 Gy) at least as good (and possibly better?) than 15 fractions @icr.ac.uk #ESTRO2025

1 4 10

Reposted by Alison Tree

National Prostate Cancer Audit @npca-natcan.bsky.social · Apr 28

⚠️ Another key finding of this study is that higher rates of metastatic prostate cancer were seen in regions with lower rates of prostate cancer diagnosis overall which may be linked to variation in the use of PSA testing.

1 2 2

Reposted by Alison Tree

Fumiko Ladd Chino, MD FASCO @fumikochino.bsky.social · Apr 9

#Radonc representation on @NCCN Treatment Guideline Committees is <10%, even for committees that recommend #radiation.

Additionally, certain institutions have nominated relatively few ☢️👩‍⚕️ for their designated slots.

Glad to see this 📰 finally published.

www.advancesradonc.org/article/S245...

Representation of Radiation Oncologists on National Comprehensive Cancer Network Guideline Committees

The National Comprehensive Cancer Network (NCCN) guideline committees play a vital role in defining the standard of care for cancer management. Equitable specialty representation is crucial for unbias...

www.advancesradonc.org

3 5